Association between bacterial vaginosis and Herpes simplex virus type-2 infection: Implications for HIV acquisition studies

Sexually Transmitted Infections

Volumn 83, Issue 5, 2007, Pages 365-368

  Nagot, Nicolas ^a,b   Ouedraogo, Abdoulaye ^b   Defer, Marie Christine ^b   Vallo, Roselyne ^b   Mayaud, Philippe ^a   Van De Perre, Philippe ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CENTRE MURAZ   (Burkina Faso)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; NYSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENITAL CANDIDIASIS; GENITAL TRACT INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SINGLE DRUG DOSE; TRICHOMONIASIS; VAGINITIS;

ADOLESCENT; ADULT; BURKINA FASO; COHORT STUDIES; CONDOMS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSTITUTION; SEXUAL PARTNERS; VAGINOSIS, BACTERIAL;

EID: 34547810946     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.024794     Document Type: Article

References (20)

1. Mayaud P. Tackling bacterial vaginosis and HIV in developing countries. Lancet 1997;350:530-1.
2. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546-50.
3. Myer L, Denny L, Telerant R, et al. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 2005;192:1372-80.
4. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-8.
5. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. Aids 1998;12:1699-706.
6. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. Aids 2000;20:73-83.
7. Cherpes TL, Meyn LA, Krohn MA, et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003;37:319-25.
8. Cherpes TL, Melan MA, Kant JA, et al. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005;40:1422-8.
9. Nagot N, Ouedraogo A, Ouangre A, et al. Is sexually transmitted infection management among sex workers still able to mitigate the spread of HIV infection in West Africa? J Acquir Immune Defic Syndr 2005;39:454-8.
10. van Dyck E, Buve A, Weiss HA, et al. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol 2004;42:2961-5.
11. Meda N, Gautier-Charpentier L, Soudre RB, et al. Serological diagnosis of human immune-deficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits. Bull World Health Organ 1999;77:731-9.
12. Boeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 2001;185:380-5.
13. Morison L, Ekpo G, West B, et al. Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women. Sex Transm Inf 2005;81:242-7.
14. Fraser NW, Valyi-Nagy T. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb Pathog 1993;15:83-91.
15. Bukusi EA, Cohen CR, Meier AS, et al. Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex Transm Dis 2006;33:361-7.
16. Demba E, Morison L, van der Loeff MS, et al. Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa. BMC Infect Dis 2005;5:12.
17. Nagot N, Meda N, Ouangre A, et al. Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV control. Sex Transm Inf 2004;80:124-9.
18. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDs prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999;353:525- 35.
19. Kaul R, Kimani J, Nagelkerke NJ, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. Jama 2004;291:2555-62.
20. Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001;185:1209-17.